Neurobiological Technologies Stock Forecast - Naive Prediction
| NTII Stock | USD 0.0001 0.00 0.00% |
The Naive Prediction forecasted value of Neurobiological Technologies on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Neurobiological Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Neurobiological Technologies' historical fundamentals, such as revenue growth or operating cash flow patterns.
Neurobiological | Build AI portfolio with Neurobiological Stock |
Neurobiological Technologies Cash Forecast
Predicting cash flow or other financial metrics requires analysts to utilize a variety of statistical methods, techniques, and algorithms. These tools help uncover hidden patterns in the Neurobiological Technologies' financial statements, enabling forecasts of their impact on future stock prices.
Cash | First Reported 2010-12-31 | Previous Quarter 2.8 M | Current Value 2.6 M | Quarterly Volatility 1.2 M |
Neurobiological Technologies Naive Prediction Price Forecast For the 2nd of January
Given 90 days horizon, the Naive Prediction forecasted value of Neurobiological Technologies on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Neurobiological Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Neurobiological Technologies' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Neurobiological Technologies Stock Forecast Pattern
| Backtest Neurobiological Technologies | Neurobiological Technologies Price Prediction | Buy or Sell Advice |
Neurobiological Technologies Forecasted Value
In the context of forecasting Neurobiological Technologies' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Neurobiological Technologies' downside and upside margins for the forecasting period are 0.0001 and 0.0001, respectively. We have considered Neurobiological Technologies' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Neurobiological Technologies stock data series using in forecasting. Note that when a statistical model is used to represent Neurobiological Technologies stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 30.385 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Neurobiological Technologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neurobiological Technologies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Neurobiological Technologies
For every potential investor in Neurobiological, whether a beginner or expert, Neurobiological Technologies' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Neurobiological Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Neurobiological. Basic forecasting techniques help filter out the noise by identifying Neurobiological Technologies' price trends.Neurobiological Technologies Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neurobiological Technologies stock to make a market-neutral strategy. Peer analysis of Neurobiological Technologies could also be used in its relative valuation, which is a method of valuing Neurobiological Technologies by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Neurobiological Technologies Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Neurobiological Technologies' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Neurobiological Technologies' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Neurobiological Technologies Market Strength Events
Market strength indicators help investors to evaluate how Neurobiological Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neurobiological Technologies shares will generate the highest return on investment. By undertsting and applying Neurobiological Technologies stock market strength indicators, traders can identify Neurobiological Technologies entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Historical Fundamental Analysis of Neurobiological Technologies to cross-verify your projections. For more detail on how to invest in Neurobiological Stock please use our How to Invest in Neurobiological Technologies guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurobiological Technologies. If investors know Neurobiological will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurobiological Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Neurobiological Technologies is measured differently than its book value, which is the value of Neurobiological that is recorded on the company's balance sheet. Investors also form their own opinion of Neurobiological Technologies' value that differs from its market value or its book value, called intrinsic value, which is Neurobiological Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurobiological Technologies' market value can be influenced by many factors that don't directly affect Neurobiological Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurobiological Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurobiological Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurobiological Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.